Comparing the Top Two: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), Green Plains, Inc. (NASDAQ:GPRE)

u.s stocks , earnings estimates, stock overview, earning reaction history, nasdaq, nyse

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) closed at $6.35 on the last trading session with an increase of 2.25%, whereas, it previously closed at $6.21. The company has a market capitalization of $645.6 Million. The company traded shares of 2.59 Million on the trading day while its three month average volume stands at 1.66 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) produced diluted EPS of -0.12. The EPS estimate for next year as estimated by analysts is at 0.57 while EPS for next quarter is estimated at 0.1. Earnings per Share growth for this year is reported at -54.4, while the analysts estimated the EPS growth for next year at 0.57% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -4.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is at 0 while the forward p/e is at 11.1. The P/S or Price to Sales ratio of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stands at 15.45 and Price to Book or P/B for the most recent quarter stands at 10.24. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) are reported at 5.1 and 5.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stands at -18, -21 and -69.5 respectively

The trailing twelve month Revenue of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is reported at 41.8 Million with income of -12000000. The outstanding shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) are 101.67 Million. The institutional Ownership of the shares of 61.4 stands at 0.80%, this figure is increased 2.64 in the last six months. The insider ownership for the shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is ticked at 4.6%, the figure is rose 0.54% in the last six months.

Some other important financial aspects to be discussed here for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is the Mean Target Price estimated by the analysts which stands at 9.33. The 52 week high of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is placed at 7.67 and 52 week low is standing at 1.85.

Performance wise the shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) fell down -4.22% for the week, it also rise 18.47% for the monthly performance, while for the quarter it went down 67.11%. The shares increase 106.17% for the half year and flew up for the Year-To-Date performance. The shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) grew 98.44% for the yearly performance.

Green Plains, Inc. (NASDAQ:GPRE)

Green Plains, Inc. (NASDAQ:GPRE) closed at $11.1 on the last trading session with an increase of 2.87%, whereas, it previously closed at $10.79. The company has a market capitalization of $427.79 Million. The company traded shares of 1.31 Million on the trading day while its three month average volume stands at 1.01 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Green Plains, Inc. (NASDAQ:GPRE) produced diluted EPS of -1.29. The EPS estimate for next year as estimated by analysts is at -0.78 while EPS for next quarter is estimated at -1.08. Earnings per Share growth for this year is reported at 138.8, while the analysts estimated the EPS growth for next year at -0.78% and Earnings growth for next 5 years stands at 15% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -19.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Green Plains, Inc. (NASDAQ:GPRE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Green Plains, Inc. (NASDAQ:GPRE) stands at 0.13 and Price to Book or P/B for the most recent quarter stands at 0.51. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Green Plains, Inc. (NASDAQ:GPRE) are reported at 0.6 and 1.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Green Plains, Inc. (NASDAQ:GPRE) stands at -2.1, -5.2 and 7.2 respectively

The trailing twelve month Revenue of Green Plains, Inc. (NASDAQ:GPRE) is reported at 3.35 Billion with income of -46800000. The outstanding shares of Green Plains, Inc. (NASDAQ:GPRE) are 38.54 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is decreased -1.46 in the last six months. The insider ownership for the shares of Green Plains, Inc. (NASDAQ:GPRE) is ticked at 15.8%, the figure is plummeted -3.66% in the last six months.

Some other important financial aspects to be discussed here for Green Plains, Inc. (NASDAQ:GPRE) is the Mean Target Price estimated by the analysts which stands at 18. The 52 week high of Green Plains, Inc. (NASDAQ:GPRE) is placed at 19.39 and 52 week low is standing at 7.01.

Performance wise the shares of Green Plains, Inc. (NASDAQ:GPRE) rose up 10.23% for the week, it also rise 55.24% for the monthly performance, while for the quarter it went up -9.02%. The shares decrease -32.85% for the half year and plummeted for the Year-To-Date performance. The shares of Green Plains, Inc. (NASDAQ:GPRE) shrinked -36.93% for the yearly performance.